These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 15286358

  • 1. A race to the starting line.
    Vogel G.
    Science; 2004 Jul 30; 305(5684):632-5. PubMed ID: 15286358
    [No Abstract] [Full Text] [Related]

  • 2. [Doping: effectiveness, consequences, prevention].
    Guezennec CY.
    Ann Endocrinol (Paris); 2001 Feb 30; 62(1 Pt 1):33-41. PubMed ID: 11240405
    [Abstract] [Full Text] [Related]

  • 3. Are drugs winning the games?
    Sullivan R, Song S.
    Time; 2000 Sep 11; 156(11):90-2. PubMed ID: 11067230
    [No Abstract] [Full Text] [Related]

  • 4. Doping in the recombinant era: strategies and counterstrategies.
    Azzazy HM, Mansour MM, Christenson RH.
    Clin Biochem; 2005 Nov 11; 38(11):959-65. PubMed ID: 16286094
    [Abstract] [Full Text] [Related]

  • 5. A half-century of anabolic steroids in sport.
    Bowers LD, Clark RV, Shackleton CH.
    Steroids; 2009 Mar 11; 74(3):285-7. PubMed ID: 19428435
    [No Abstract] [Full Text] [Related]

  • 6. Gene doping.
    Haisma HJ, de Hon O.
    Int J Sports Med; 2006 Apr 11; 27(4):257-66. PubMed ID: 16572366
    [Abstract] [Full Text] [Related]

  • 7. Can anabolic steroids or human growth hormone affect the growth and maturation of adolescent athletes?
    Rogol AD.
    Pediatr Exerc Sci; 2014 Nov 11; 26(4):423-7. PubMed ID: 25372376
    [No Abstract] [Full Text] [Related]

  • 8. [Hormonal substances used as ergogenic agents].
    Laudo Pardos C, Puigdevall Gallego V, del Río Mayor MJ.
    Med Clin (Barc); 1999 Jan 23; 112(2):67-73. PubMed ID: 10065435
    [No Abstract] [Full Text] [Related]

  • 9. Stay alert for performance-enhancing substance use.
    Jarvi JF.
    JAAPA; 2004 Dec 23; 17(12):36-9. PubMed ID: 15631019
    [No Abstract] [Full Text] [Related]

  • 10. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent?
    Rogol AD.
    Growth Horm IGF Res; 2009 Aug 23; 19(4):294-9. PubMed ID: 19487146
    [Abstract] [Full Text] [Related]

  • 11. Rogue athletes and recombinant DNA technology: challenges for doping control.
    Azzazy HM, Mansour MM.
    Analyst; 2007 Oct 23; 132(10):951-7. PubMed ID: 17893796
    [Abstract] [Full Text] [Related]

  • 12. [Doping and urologic tumors].
    Pinto F, Sacco E, Volpe A, Gardi M, Totaro A, Calarco A, Racioppi M, Gulino G, D'Addessi A, Bassi PF.
    Urologia; 2010 Oct 23; 77(2):92-9. PubMed ID: 20890867
    [Abstract] [Full Text] [Related]

  • 13. Medicine and science in the fight against doping in sport.
    Catlin DH, Fitch KD, Ljungqvist A.
    J Intern Med; 2008 Aug 23; 264(2):99-114. PubMed ID: 18702750
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Commentary on Graham et al.: physical effects of short-term rhGH administration in abstinent steroid dependency.
    Sonksen PH, Holt RI.
    Horm Res; 2008 Aug 23; 69(6):355-6. PubMed ID: 18504394
    [No Abstract] [Full Text] [Related]

  • 19. [Identification of candidate genes and expression profiles, as doping biomarkers].
    Paparini A, Impagnatiello F, Pistilli A, Rinaldi M, Gianfranceschi G, Signori E, Stabile AM, Fazio V, Rende M, Romano Spica V.
    Ann Ig; 2007 Aug 23; 19(4):303-14. PubMed ID: 17937323
    [Abstract] [Full Text] [Related]

  • 20. Doping, gene transfer and sport.
    Verma IM.
    Mol Ther; 2004 Sep 23; 10(3):405. PubMed ID: 15336640
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.